Drug intelligence / Profile preview

HMCuS + platinum + indocyanine green

Development stage
Unknown
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nanoparticles → Drug Delivery Systems, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
01

Overview

This appears to be an experimental combination of three components: HMCuS (likely a copper sulfide-based nanoparticle or material), platinum (likely a platinum-based chemotherapeutic agent or nanoparticle), and indocyanine green (ICG, a FDA-approved near-infrared fluorescent dye). Based on the search results, ICG is a tricarbocyanine molecule with fluorescent properties used in medical diagnostics and increasingly in surgical oncology applications. ICG has a molecular mass of 776 Daltons, binds to plasma proteins after intravenous injection, and is metabolized by the liver. It exhibits peak spectral absorption at approximately 800 nm and emission at 822 nm. The combination likely represents a theranostic (therapeutic and diagnostic) nanoplatform that may utilize ICG's fluorescence imaging capabilities for tumor visualization, platinum's cytotoxic properties for cancer treatment, and HMCuS's potential photothermal or photodynamic properties. However, specific information about this exact combination formulation is not available in the provided search results.

Beyond the preview

Go deeper on HMCuS + platinum + indocyanine green.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HMCuS + platinum + indocyanine green.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call